Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 68 Head & Neck 43 Thoracic 11 Tumor-Agnostic 7 CNS 5 Gynecologic 4 Breast 3 Sarcoma 2 Genitourinary 2 Plasma cell 1 Other solid neoplasm 1 Myeloid 1 Lymphoid 1 Dermatologic 1

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 116 Bortezomib 63 Cyclophosphamide 51 Lenalidomide 49 Calcium Dobesilate 46 Melphalan 37 pomalidomide 36 fludarabine 28 Filgrastim 26 fludarabine phosphate 23 carfilzomib 22 daratumumab 21 Whole-Body Irradiation 17 Granulocyte Colony-Stimulating Factor 17 Mycophenolic Acid 15 Antilymphocyte Serum 15 dexamethasone acetate 14 Tacrolimus 14 Thalidomide 13 Cyclosporine 13 Busulfan 13 Radiotherapy 12 Peripheral Blood Stem Cell Transplantation 12 ixazomib 11 dexamethasone 21-phosphate 10 auricularum 10 pembrolizumab 9 Stem Cell Transplantation 9 Rituximab 9 Etoposide 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Cetuximab × Plasma cell × Clear all

NCT00368121 2012-07-13

EMMA-1

University of Cologne

Phase 2 Terminated

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡